Literature DB >> 16495532

Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.

Christopher E Thomas1, Weiyan Zhu, Cornelius N Van Dam, Nancy L Davis, Robert E Johnston, P Frederick Sparling.   

Abstract

We investigated the immunogenicity of gonococcal transferrin binding protein B (TbpB) expressed with and without a eukaryotic secretion signal from a nonpropagating Venezuelan equine encephalitis virus replicon particle (VRP) delivery system. TbpB was successfully expressed in baby hamster kidney (BHK) cells, and the presence of the eukaryotic secretion signal not only apparently increased the protein's expression but also allowed for extracellular localization and glycosylation. Mice immunized with VRPs produced significant amounts of serum antibody although less than the amounts produced by mice immunized with recombinant protein. The response of mice immunized with VRPs encoding TbpB was consistently more Th1 biased than the response of mice immunized with recombinant protein alone. Boosting with recombinant protein following immunization with TbpB VRPs resulted in higher specific-antibody levels without altering the Th1/Th2 bias. Most of the immunization groups produced significant specific antibody binding to the intact surface of the homologous Neisseria gonorrhoeae strain. Immunization with TbpB VRPs without a eukaryotic secretion signal generated no measurable specific antibodies on the genital mucosal surface, but inclusion of a eukaryotic secretion signal or boosting with recombinant protein resulted in specific immunoglobulin G (IgG) and IgA in mucosal secretions after TbpB VRP immunization. The TbpB VRP system has potential for an N. gonorrhoeae vaccine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495532      PMCID: PMC1418633          DOI: 10.1128/IAI.74.3.1612-1620.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Macropinocytosis as a mechanism of entry into primary human urethral epithelial cells by Neisseria gonorrhoeae.

Authors:  M K Zenni; P C Giardina; H A Harvey; J Shao; M R Ketterer; D M Lubaroff; R D Williams; M A Apicella
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors:  N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.

Authors:  Patrick R Harrington; Boyd Yount; Robert E Johnston; Nancy Davis; Christine Moe; Ralph S Baric
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 4.  Alphavirus DNA and particle replicons for vaccines and gene therapy.

Authors:  J M Polo; J P Gardner; Y Ji; B A Belli; D A Driver; S Sherrill; S Perri; M A Liu; T W Dubensky
Journal:  Dev Biol (Basel)       Date:  2000

5.  Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA.

Authors:  M P Velders; S McElhiney; M C Cassetti; G L Eiben; T Higgins; G R Kovacs; A G Elmishad; W M Kast; L R Smith
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

6.  Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system.

Authors:  J S Lee; P Pushko; M D Parker; M T Dertzbaugh; L A Smith; J F Smith
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

7.  Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles.

Authors:  U B Balasuriya; H W Heidner; J F Hedges; J C Williams; N L Davis; R E Johnston; N J MacLachlan
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus.

Authors:  P Pushko; M Bray; G V Ludwig; M Parker; A Schmaljohn; A Sanchez; P B Jahrling; J F Smith
Journal:  Vaccine       Date:  2000-08-15       Impact factor: 3.641

9.  Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.

Authors:  Gregory A Price; Michael W Russell; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

10.  Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

Authors:  D West; K Reddin; M Matheson; R Heath; S Funnell; M Hudson; A Robinson; A Gorringe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

View more
  13 in total

1.  Identification of TbpA residues required for transferrin-iron utilization by Neisseria gonorrhoeae.

Authors:  Jennifer M Noto; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

2.  Conserved regions of gonococcal TbpB are critical for surface exposure and transferrin iron utilization.

Authors:  Karen L Ostberg; Amanda J DeRocco; Shreni D Mistry; Mary Kathryne Dickinson; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

3.  The genes that encode the gonococcal transferrin binding proteins, TbpB and TbpA, are differentially regulated by MisR under iron-replete and iron-depleted conditions.

Authors:  Justin L Kandler; Rosuany Vélez Acevedo; Mary Kathryne Dickinson; Devin R Cash; William M Shafer; Cynthia Nau Cornelissen
Journal:  Mol Microbiol       Date:  2016-07-18       Impact factor: 3.501

Review 4.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

5.  Neisseria gonorrhoeae Evades Calprotectin-Mediated Nutritional Immunity and Survives Neutrophil Extracellular Traps by Production of TdfH.

Authors:  Sophonie Jean; Richard A Juneau; Alison K Criss; Cynthia N Cornelissen
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

6.  Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.

Authors:  Guocai Li; Hongmei Jiao; Guihua Jiang; Jing Wang; Litian Zhu; Rushan Xie; Hua Yan; Hongju Chen; Mingchun Ji
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

7.  Identification of transferrin-binding domains in TbpB expressed by Neisseria gonorrhoeae.

Authors:  Amanda J DeRocco; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2007-04-16       Impact factor: 3.441

8.  An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.

Authors:  Hoyin Mok; Sharon J Tollefson; Amy B Podsiad; Bryan E Shepherd; Vasiliy V Polosukhin; Robert E Johnston; John V Williams; James E Crowe
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

9.  Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs.

Authors:  Dal Young Kim; Svetlana Atasheva; Alexander J McAuley; Jessica A Plante; Elena I Frolova; David W C Beasley; Ilya Frolov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-07       Impact factor: 11.205

10.  A novel strategy of epitope design in Neisseria gonorrhoeae.

Authors:  Debmalya Barh; Amarendra Narayan Misra; Anil Kumar; Azevedo Vasco
Journal:  Bioinformation       Date:  2010-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.